Cardiocap Tm CT-104 Monitor
by Datex Division Instrumentarium Corp.
510(k) K897080
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK897080 | Date6 Mar 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DRT
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2300
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This device is a Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm) as defined in the device specifications. It is a Class II cardiac monitor manufactured by Datex Division Instrumentarium Corp.
The device received FDA 510(k) clearance under K-number K897080 on March 6, 1990, and is substantially equivalent to a predicate device. It is used in cardiovascular settings and is supplied as a reusable monitoring system for cardiac activity, including rate and rhythm assessment.
Other devices from Datex Division Instrumentarium Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the CARDIOCAP(TM) CT-104 MONITOR used for?
The CARDIOCAP(TM) CT-104 MONITOR is used in cardiovascular settings to monitor cardiac activity, including rate and rhythm assessment, as a cardiac monitor with cardiotachometer and rate alarm functions.
Is the CARDIOCAP(TM) CT-104 MONITOR reusable or single-use?
The CARDIOCAP(TM) CT-104 MONITOR is supplied as a reusable monitoring system, meaning it is designed for multiple uses after appropriate cleaning and maintenance, not for single-use disposal.
What regulatory clearance does the CARDIOCAP(TM) CT-104 MONITOR have?
The device received FDA 510(k) clearance under K-number K897080 on March 6, 1990, and is substantially equivalent to a predicate device, which means it meets the regulatory requirements for market entry through the traditional 510(k) pathway.